Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06035523 · ClinicalTrials.gov registry record · NA
Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™
A NA study of Diabetic Foot and Foot Ulcer, sponsored by Aroa Biosurgery Limited.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 4
- Study locations
NCT06035523 is a NA study of Diabetic Foot and Foot Ulcer that has completed, run by Aroa Biosurgery Limited. The registered enrollment target is 44 participants, below the 10,340-participant average among 30 other Diabetic Foot trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT06035523, a NA study of Diabetic Foot and Foot Ulcer, has completed, sponsored by Aroa Biosurgery Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 4
- Study locations
Study Summary
Study will evaluate the performance and safety of Endoform™ Natural and Endoform™ Antimicrobial in conjunction with Symphony™ in the treatment of chronic non-healing diabetic foot ulcers after 12 weeks of treatment.
Conditions Studied
Interventions
- DEVICE Endoform™ Antibacterial
- DEVICE Endoform™ Natural
- DEVICE Symphony™
Study Locations (4)
Florida
- South Florida Lower Extremity Center - Hollywood
- Advanced Pharma Cr, LLC - Miami
Virginia
- Foot and Ankle Specialists of the Mid-Atlantic - Salem
Washington
- Madigan Army Medical Center - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-12-29 |
| Est. Completion | 2025-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06035523
The ClinicalTrials.gov registry entry for NCT06035523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,340-participant average among 30 other Diabetic Foot trials with a reported enrollment target (100% lower). The listed sponsor is Aroa Biosurgery Limited, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 3 interventions - of which Endoform™ Antibacterial is the first listed.
NCT06035523 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Florida, Virginia, Washington.
Frequently Asked Questions
What is clinical trial NCT06035523 about?
NCT06035523 is a clinical study titled "Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™". Study will evaluate the performance and safety of Endoform™ Natural and Endoform™ Antimicrobial in conjunction with Symphony™ in the treatment of chronic non-healing diabetic foot ulcers after 12 weeks of treatment.
What is the current status of trial NCT06035523?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2021-12-29. Estimated completion is 2025-08-30.
What conditions does trial NCT06035523 study?
This clinical trial studies the following conditions: Diabetic Foot, Foot Ulcer, Wound Healing, Chronic Foot Ulcer.
What interventions are being tested in trial NCT06035523?
The interventions under investigation include: Endoform™ Antibacterial (DEVICE), Endoform™ Natural (DEVICE), Symphony™ (DEVICE).
Who is sponsoring clinical trial NCT06035523?
This trial is sponsored by Aroa Biosurgery Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06035523 being conducted?
This trial has 4 study locations across Florida, Virginia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Effectiveness of Remote Foot Temperature Monitoring
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
RECRUITING · NA
-
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
RECRUITING · NA
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.